Transendothelial migration experiments were performed as describe

Transendothelial migration experiments were performed as described previously 18. In brief, 3.0-μm pore polyester membrane transwell inserts (Corning) were coated with 100 μg/mL fibronectin and 400 μg/mL collagen type IV (Sigma-Aldrich) for 30–60 min before 1.5×105 HBMEC were added. 500 IU/mL TNF-α and 500 IU/mL IFN-γ (R&D, Minneapolis, MN, USA) were added to the lower compartment 4 h after the addition of HBMEC for some experiments. Incubation time for the endothelial monolayer was carefully titrated according to confluence and firm intraendothelial adhesion, determined

by immunohistochemical stainings of the tight junction protein occludin, and the electrical resistance of the Sorafenib order endothelial monolayer (TEER). PBMC or CD4+ T cells were seeded onto the confluent BMEC monolayer 16 h after activation of the endothelium and the PLX-4720 cost T-cell phenotypes in the lower compartment

were analyzed after a 12-h incubation time. Human PBMC were isolated by centrifugation of donor blood on a Lymphoprep (Fresenius Kabi Norge AS) density gradient. To allow comparative analysis of cells from patients with RR-MS and healthy controls, PBMC were immediately cryopreserved and stored in liquid nitrogen. Human CD4+CD25high Treg were isolated using MACS technology (Miltenyi) according to the supplier’s manual. Cells were washed twice in PBS containing 0.1% sodium azide and 1% bovine serum albumin and incubated for 30 min with monoclonal antibodies for different T-cell surface antigens. The following anti-human monoclonal antibodies were used (all fluorochrome-conjugated): anti-CD4 (SK3), (BD Biosciences),

anti-CD4 (M-T466) (Ebioscience) and anti-VCAM-1 (1G11B1) (Abcam). The respective isotype controls (mouse IgG1, rat IgG2a, mouse IgG1) were purchased from BD Biosciences. Intracellular staining using anti-human and anti-murine-Foxp3 (clones PCH101 and FJK-16s, respectively) antibodies were performed using Foxp3 staining kits (Ebiosciences) according to the manufacturer’s protocol. AntiCD4 (RM4-5), anti-CD44 (IM7), anti-CD73 (TY-11-8), anti-CD62L (MEL-14), anti-CD69 (H1.2F3), anti LFA-1 (2D7), anti-CCR5 (C34-3448), anti-CCR7 (150503), anti-CD49d (9C10) (BD Biosciences), anti-CCR6 (140706) (R&D), anti CD49a (804) (Serotec) and anti-CD49f (GoH3) (Biolegend) RVX-208 monoclonal antibodies were used for flow cytometry of murine T cells. Data were acquired on a FACSCalibur flow cytometer (BD) and analyzed using FlowJo software 7.5 (Tree Star). HBMEC cultures were fixed at different incubation time points with 4% paraformaldehyde, blocked with 30% donkey serum (PAA) for 60 min, incubated with goat-anti-human ICAM-1 (British Biotechnology) for 1 h and subsequently stained with donkey-anti-goat Cy2 (Dianova) for another 60 min. Cover slips for migration analysis were coated with 20 μg/mL laminin (Sigma-Aldrich (after precoating with 10 μg/mL poly-D-lysine (Sigma-Aldrich)) and were transferred to migration chambers.

Comments are closed.